GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » MusclePharm Corp (OTCPK:MSLPQ) » Definitions » E10

MusclePharm (MusclePharm) E10 : $-1.70 (As of Mar. 2022)


View and export this data going back to 2008. Start your Free Trial

What is MusclePharm E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

MusclePharm's adjusted earnings per share data for the three months ended in Mar. 2022 was $-0.190. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.70 for the trailing ten years ended in Mar. 2022.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-03), MusclePharm's current stock price is $0.0012. MusclePharm's E10 for the quarter that ended in Mar. 2022 was $-1.70. MusclePharm's Shiller PE Ratio of today is .


MusclePharm E10 Historical Data

The historical data trend for MusclePharm's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MusclePharm E10 Chart

MusclePharm Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -55.20 -51.32 -50.78 -11.72 -2.99

MusclePharm Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.82 -4.86 -4.79 -2.99 -1.70

Competitive Comparison of MusclePharm's E10

For the Packaged Foods subindustry, MusclePharm's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MusclePharm's Shiller PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, MusclePharm's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where MusclePharm's Shiller PE Ratio falls into.



MusclePharm E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MusclePharm's adjusted earnings per share data for the three months ended in Mar. 2022 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2022 (Change)*Current CPI (Mar. 2022)
=-0.19/121.3010*121.3010
=-0.190

Current CPI (Mar. 2022) = 121.3010.

MusclePharm Quarterly Data

per share eps CPI Adj_EPS
201206 3.780 96.819 4.736
201209 -3.210 97.633 -3.988
201212 -3.380 96.871 -4.232
201303 -1.780 98.209 -2.199
201306 -0.340 98.518 -0.419
201309 -0.470 98.790 -0.577
201312 -0.390 98.326 -0.481
201403 0.230 99.695 0.280
201406 -0.090 100.560 -0.109
201409 0.050 100.428 0.060
201412 -1.390 99.070 -1.702
201503 -0.560 99.621 -0.682
201506 -0.510 100.684 -0.614
201509 -2.010 100.392 -2.429
201512 -0.690 99.792 -0.839
201603 -0.480 100.470 -0.580
201606 -0.300 101.688 -0.358
201609 -0.100 101.861 -0.119
201612 0.620 101.863 0.738
201703 -0.230 102.862 -0.271
201706 -0.230 103.349 -0.270
201709 -0.150 104.136 -0.175
201712 -0.180 104.011 -0.210
201803 -0.170 105.290 -0.196
201806 -0.020 106.317 -0.023
201809 -0.090 106.507 -0.103
201812 -0.440 105.998 -0.504
201903 -0.300 107.251 -0.339
201906 -0.380 108.070 -0.427
201909 -0.270 108.329 -0.302
201912 -0.105 108.420 -0.117
202003 -0.002 108.902 -0.002
202006 -0.010 108.767 -0.011
202009 0.010 109.815 0.011
202012 0.060 109.897 0.066
202103 0.002 111.754 0.002
202106 -0.070 114.631 -0.074
202109 -0.120 115.734 -0.126
202112 -0.200 117.630 -0.206
202203 -0.190 121.301 -0.190

Add all the adjusted EPS together and divide 10 will get our e10.


MusclePharm  (OTCPK:MSLPQ) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


MusclePharm E10 Related Terms

Thank you for viewing the detailed overview of MusclePharm's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


MusclePharm (MusclePharm) Business Description

Traded in Other Exchanges
N/A
Address
6728 W. Sunset Road, Suite 130, Las Vegas, NV, USA, 89118
MusclePharm Corporation is a performance lifestyle company. It develops, manufactures, markets and distributes branded nutritional supplements. It offers various types of powders, capsules, tablets and gels. Geographically, the firm has its business presence across the region of US and in the international market of which the US accounts for the majority of revenue. MusclePharm's Hybrid series products include Assault, Combat Protein Powder, BCAA 3:1:2, CLA Core, Fish Oil, Combat Crunch Protein Bars, glutamine, carnitine, Combat Crunch, Protein Crisp, Organic Protein, and Protein Cookie. The group sells its products to various fitness enthusiasts, such as professional, combat sport, weight training, bodybuilding, running, and various team and individual sports, and others.
Executives
Eric Chin officer: Chief Accounting Officer 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Paul W Karr director BRISTOL MEYERS SQUIBB CO, 345 PARK AVENUE, NEW YORK NY 10154
Sabina Rizvi officer: President & CFO 6728 W. SUNSET ROAD, SUITE 130, LAS VEGAS NV 89118
Michael David Heller director 4500 PARK GRANADA, SUITE 202, CALABASAS CA 91302
Wynnefield Partners Small Cap Value Lp I 10 percent owner 450 SEVENTH AVENUE, SUITE 509, NEW YORK NY 10123
Donald Feagan 10 percent owner 2150 SOUTH 1300 EAST STREET, SUITE 500, SALT LAKE CITY UT 84106
Amerop Holdings, Inc. 10 percent owner 1800 BROADWAY, SUITE 100, BOULDER CO 80302
White Winston Select Asset Fund Series Fund Mp-18, Llc 10 percent owner C/O WHITE WINSTON SELECT ASSET FUNDS, LLC, 265 FRANKLIN ST., SUITE 1702, BOSTON MA 02110
Robert P Mahoney 10 percent owner 4 DANIELS FARM ROAD, #305, TRUMBULL CT 06611
White Winston Select Asset Funds, Llc 10 percent owner 265 FRANKLIN STREET, SUITE 1702, BOSTON MA 02110
Todd M. Enright 10 percent owner 2150 SOUTH 1300 EAST STREET, SUITE 500, SALT LAKE CITY UT 84106
Mark Blundell 10 percent owner 8 MACDONALD AVE, ARMOUK NY 10504
John J Desmond director 10 GLEN HEAD ROAD, GLEN HEAD NY 11545
Wynnefield Small Cap Value Offshore Fund Ltd 10 percent owner 450 SEVENTH AVE, STE 509, NEW YORK NY 10123
Wynnefield Capital Inc 10 percent owner 450 SEVENTH AVE, STE 509, NEW YORK NY 10123